It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar.

This week we launched our 50-page Prescription Digital Therapeutics (PDT) Report. The report was created in collaboration with Brian Dolan of Exits & Outcomes (E&O). This report contains key examples of PDT applications, industry implications and a critical viewpoint; find out more in this blog.

We are excited to give you a sneak peek into our upcoming report on Prescription Digital Therapeutics. 

As 2021 kicked off with the first-ever virtual J.P. Morgan, HealthXL collaborated with BrightInsight to bring together global leaders from across healthcare, medtech and life sciences to a Digital Health C-Suite meeting series. Here are our key takeaways!

Covid-19 has accelerated the adoption of digital health by people all over the world and APAC is no exception. We explore this adoption in this week's blog.

You’ve probably seen the images of lots of people with big smiles, thumbs up on social media. Those are the participants at HealthXL Interactive. We thought getting a group of people together on Zoom and running a few meetings is going to be easy, breezy.

Slowly we are seeing payers embrace the true value and potential of digital and yet, it is difficult to ascertain to what extent leading insurers are actually engaging with digital. With this in mind we assessed the digital health maturity of leading plans in the United States.

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines?

Our Quarterly research report is now Live! This quarter, we assessed the digital health maturity of the Top 10 pharmaceutical companies (by revenue) over the past 5 years in the following four areas - investment, acquisition, partnerships, and hiring initiatives. 

The Digital Health Evidence Review 2019 report aims to identify, categorize, and summarize all existing, relevant studies in digital health. In this report, we have to established a clear understanding of the existing body of clinical evidence for digital health, its maturity, current gaps and needs